Brazil will participate in the final phase of the vaccine trials of Janssen-Cilag, the pharmaceutical division of Johnson & Johnson. Meanwhile, Cuban state media reported that Cuban researchers will begin testing their experimental vaccine against the new coronavirus, called Soberana 01, on August 24. They seek to have results of their trials in February 2021.
Brazil authorizes trial of Johnson & Johnson vaccine
2020-08-19T21:19:13.878Z
Brazil will participate in the final phase of the vaccine trials of Janssen-Cilag, the pharmaceutical division of Johnson & Johnson. Meanwhile, Cuban state media reported that investigated ...
